.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Daiichi Sankyo
Accenture
Medtronic
Chubb
Julphar
Fuji
Farmers Insurance
Queensland Health
QuintilesIMS

Generated: November 19, 2017

DrugPatentWatch Database Preview

Emd Serono Company Profile

« Back to Dashboard

What is the competitive landscape for EMD SERONO, and when can generic versions of EMD SERONO drugs launch?

EMD SERONO has thirteen approved drugs.

There are five US patents protecting EMD SERONO drugs.

There are one hundred and four patent family members on EMD SERONO drugs in thirty-nine countries and twelve supplementary protection certificates in six countries.

Summary for Emd Serono

International Patents:104
US Patents:5
Tradenames:13
Ingredients:8
NDAs:13
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emd Serono
GONAL-F
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS020378-005Mar 26, 2004RXYesYes► Subscribe► SubscribeY ► Subscribe
Emd Serono
SAIZEN
somatropin recombinant
INJECTABLE;INJECTION019764-002Oct 8, 1996BXRXYesNo► Subscribe► Subscribe► Subscribe
Emd Serono
SEROSTIM
somatropin recombinant
INJECTABLE;INJECTION020604-004Sep 6, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Emd Serono
GONAL-F
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS020378-003May 25, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Emd Serono
GONAL-F RFF REDI-JECT
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021684-001May 25, 2004RXYesYes► Subscribe► SubscribeY ► Subscribe
Emd Serono
GONAL-F
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS020378-001Sep 29, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Emd Serono
GONAL-F RFF REDI-JECT
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021684-003May 25, 2004RXYesYes► Subscribe► SubscribeY ► Subscribe
Emd Serono
ZORBTIVE
somatropin recombinant
INJECTABLE;INJECTION021597-004Dec 1, 2003RXYesYes► Subscribe► Subscribe► Subscribe
Emd Serono
GONAL-F
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021765-003Mar 25, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Emd Serono
SEROSTIM
somatropin recombinant
INJECTABLE;INJECTION020604-002Aug 23, 1996BXRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Emd Serono

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Emd Serono
OVIDREL
choriogonadotropin alfa
INJECTABLE;INJECTION021149-001Sep 20, 2000► Subscribe► Subscribe
Emd Serono Inc
CETROTIDE
cetrorelix
INJECTABLE;INJECTION021197-002Aug 11, 2000► Subscribe► Subscribe
Emd Serono
GONAL-F RFF REDI-JECT
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021684-002May 25, 2004► Subscribe► Subscribe
Emd Serono
GONAL-F
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS020378-005Mar 26, 2004► Subscribe► Subscribe
Emd Serono
GONAL-F
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS020378-004Feb 28, 2001► Subscribe► Subscribe
Emd Serono
GONAL-F
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS020378-001Sep 29, 1997► Subscribe► Subscribe
Emd Serono Inc
CETROTIDE
cetrorelix
INJECTABLE;INJECTION021197-001Aug 11, 2000► Subscribe► Subscribe
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-001Sep 26, 1997► Subscribe► Subscribe
Emd Serono Inc
CETROTIDE
cetrorelix
INJECTABLE;INJECTION021197-001Aug 11, 2000► Subscribe► Subscribe
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-001Sep 26, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Emd Serono Drugs

Country Document Number Estimated Expiration
Norway318997► Subscribe
Austria228850► Subscribe
Australia2004226666► Subscribe
Israel140984► Subscribe
South Africa200507287► Subscribe
Portugal814841► Subscribe
New Zealand507405► Subscribe
Slovakia285192► Subscribe
Eurasian Patent Organization012565► Subscribe
Finland973745► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Emd Serono Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2010000011Germany► SubscribePRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125
C0010Belgium► SubscribePRODUCT NAME: FOLLITROPINE ALPHA; NAT. REGISTRATION NO/DATE: EU1/95/001/001 19951020; FIRST REGISTRATION: FI 11529 19940815
9C0031Belgium► SubscribePRODUCT NAME: ACETATE DE CETRORELIX; REGISTRATION NO/DATE: EU/1/99/100/001 19990413
01C/020Belgium► SubscribePRODUCT NAME: LUTROPINE ALFA; REGISTRATION NO/DATE: EU/1/00/155/001 20001129
2010Austria► SubscribePRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125
C/GB10/022United Kingdom► SubscribePRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTERED: UK EU/1/09/609/001 20100125; UK EU/1/09/609/002 20100125
00440Netherlands► SubscribePRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125; FORMER OWNER: N.V. ORGANON, NL
C0024France► SubscribePRODUCT NAME: CORIFOLLITROPINE ALPHA; REGISTRATION NO/DATE: EU/1/09/609/001 20100125
/1999Austria► SubscribePRODUCT NAME: CETRORELIX UND PHARMAZEUTISCH ANNEHMBARE SAEUREADDITIONSSALZE DAVON, INSBESONDERE CETRORELIXACETAT; REGISTRATION NO/DATE: EU/1/99/100/001- EU/1/99/100/003 19990413
6/2010Austria► SubscribePRODUCT NAME: CORIFOLLITROPIN ALFA
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
QuintilesIMS
Covington
McKesson
Teva
Medtronic
Harvard Business School
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot